The aim of the study was to reveal Sox2 + GSCs marker genes raised due to the missense mutations in IDH1 and TP53. To unify the impact of background mutational load we decided to compare IDH1- and TP53-mutant glioma samples to glioma samples having the wild-type genes. This evidence concerns the gene IDH1 and central nervous system cancer.